The Riverside Company invested in Crio, a Boston, Massachusetts-based developer of eSource and other eClinical technology.
The deal’s total value was not made public.
Use of funds
With the money, the business hopes to strengthen its value offer to clinical research sites, biopharmaceutical companies, and CROs by expanding its product pipeline more quickly.
About Crio
Crio is a supplier of eSource and other eClinical solutions, and it was co-founded by co-CEOs Raymond Nomizu and Jonathan Andrus. Its eClinical platform, which includes fully integrated eSource, site CTMS, eConsent, EDC, remote monitoring, and source data verification tools, is intended to simplify research at the site level.
